Results 311 to 320 of about 77,075 (344)
Some of the next articles are maybe not open access.
Archives of Internal Medicine, 1987
From 1978 to 1982, 620 pleural fluid cytology specimens were examined, of which 80 were positive in 64 patients. Of these 64, three (0.5%) specimens had false-positive results. Adenocarcinoma of the lung was the most frequent (25 of 61) primary site, followed by breast (12 of 61), ovary (six of 61), and pancreas (five of 61).
openaire +1 more source
From 1978 to 1982, 620 pleural fluid cytology specimens were examined, of which 80 were positive in 64 patients. Of these 64, three (0.5%) specimens had false-positive results. Adenocarcinoma of the lung was the most frequent (25 of 61) primary site, followed by breast (12 of 61), ovary (six of 61), and pancreas (five of 61).
openaire +1 more source
2006
Malignant pleural effusion, a common complication of advanced malignancy, is associated with significant morbidity and mortality. The symptoms of MPE (dyspnea, cough, pleuritic pain) can be debilitating and can result in prolonged hospitalization at a considerable cost.
Roberto V. Barresi, Keith W. Millikan
openaire +1 more source
Malignant pleural effusion, a common complication of advanced malignancy, is associated with significant morbidity and mortality. The symptoms of MPE (dyspnea, cough, pleuritic pain) can be debilitating and can result in prolonged hospitalization at a considerable cost.
Roberto V. Barresi, Keith W. Millikan
openaire +1 more source
Malignant pleural effusion management
Archivos de Bronconeumología (English Edition), 2021Lucía, Ferreiro +2 more
openaire +2 more sources
Malignant Pleural Effusion: Presentation, Diagnosis, and Management
American Journal of Medicine, 2022Shameek Gayen
exaly
Seminars in oncology, 1991
Malignancy is the most common cause of exudative pleural effusion in patients over the age of 60 years. Control of the effusion significantly reduces morbidity and improves quality of life. Tube thoracostomy with subsequent chemical pleurodesis is the treatment of choice for patients with tumors that are relatively insensitive to systemic chemotherapy.
openaire +1 more source
Malignancy is the most common cause of exudative pleural effusion in patients over the age of 60 years. Control of the effusion significantly reduces morbidity and improves quality of life. Tube thoracostomy with subsequent chemical pleurodesis is the treatment of choice for patients with tumors that are relatively insensitive to systemic chemotherapy.
openaire +1 more source
Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study
Lancet, The, 2007Francisco Rodriguez-Panadero +2 more
exaly